Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000605:Amino Alcohols / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002302:Cardiac Output; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D013830:Thiadiazoles / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D014636:Valsalva Maneuver; D014655:Vascular Resistance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000959:Antihypertensive Agents; D002082:Butylamines; D009025:Morpholines; D013830:Thiadiazoles; D011433:Propranolol